Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
about
Nonalcoholic fatty liver disease as a multi-systemic diseaseResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisCardiovascular dysfunction in patients with liver cirrhosisRole of cardiovascular intervention as a bridge to liver transplantationNoninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound TechniqueNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Nonalcoholic fatty liver disease - A multisystem disease?Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver diseaseHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE.Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with NAFLD induced by a high-fat diet.Nonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging-An Experimental Study in a Rat Model.Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis.Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease.The medical risks of obesity.Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension.Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetesEffect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver diseaseQuantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Nonalcoholic fatty liver disease (NAFLD) - a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients.A simple index of lipid overaccumulation is a good marker of liver steatosis.Effect of concurrent training on risk factors and hepatic steatosis in obese adolescents.Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese populationIndependent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population.Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial.LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients.High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway.Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*).Putative factors that may modulate the effect of exercise on liver fat: insights from animal studies.Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c.Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDLThe severity of Fatty liver disease relating to metabolic abnormalities independently predicts coronary calcificationFructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis).Paternal B Vitamin Intake Is a Determinant of Growth, Hepatic Lipid Metabolism and Intestinal Tumor Volume in Female Apc1638N Mouse OffspringNonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular indexComputed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis.Cardiometabolic aspects of the polycystic ovary syndrome.
P2860
Q26749290-7D113615-F384-4A87-BC8D-BFABBBA2AA72Q26775340-33B00C1A-551F-45A9-A28D-F737E3E38A51Q27010592-1DAB5A5D-8786-44CE-82F9-1C3B24F5CD82Q27011341-1B413280-96EA-4183-A8FC-E83713881D7FQ27318751-B72DAC58-4508-4DCC-B818-57C3D6AA7481Q27692035-AC4EA7C4-1971-4EDE-BFBD-1A1FB940CFCEQ28079077-798C9442-9955-4819-A02C-780DA4A68CCBQ28543519-640A64E8-574C-4B6E-830E-14BF3E3E567AQ30234574-3D0B3D7B-6859-45BB-969F-5AE039482B84Q30390099-292F30D2-5DF7-4936-9CF2-EF02DFB9D484Q30426480-B6BC9710-C10A-49E1-BB1C-1D77D6F1F532Q31004631-4167C12A-3805-48D3-93E6-FAB95DDAA5BAQ33596784-1B936B62-BB11-44C8-BA20-73E1C7A97E99Q33706798-5E6D332C-7139-4F12-B008-968EF8B2020FQ33813264-9498F99C-4A99-4705-AFB4-0D96A640E2C3Q33888248-69AD5B33-C991-451C-9B2E-B8F6B931CBECQ33913750-A8E087AF-FA10-4F5E-95AB-5E09A5AE2C72Q33932844-64BA3B10-9BFD-436F-9F49-7523443815F4Q33984899-1D10DF1C-9627-44CD-9D7F-788DC82A8A72Q34021973-0A2DC1C6-90AE-4DD9-91E8-F152D86F4109Q34042677-BFA60189-11CE-4833-9B4A-8FEDB100F5AEQ34134206-E648F2BF-736F-43F8-A66D-CF93ACBCDADAQ34279257-F6BEB0EB-5074-4B12-8D58-00221159EFBBQ34360938-F1752ABD-1BD3-430C-ACE6-99B42C472F34Q34538219-E652B616-3C01-4306-A038-17254C93764FQ34736255-FC90A9A2-9550-4D3C-B93E-095BB69D5584Q34776084-6E68DA88-7A3F-42D7-8602-D7895D9F111BQ34802683-A68C3622-0AC6-4A0F-8D10-826F9485ADD7Q34989210-647CDFB4-8678-4FF6-AFBF-FD54EB460262Q35103486-A0777976-1C50-4FCC-978F-F71C2D0F20E3Q35201998-DFA284BE-C564-498B-8CB7-DAEF8A5B6CA4Q35258097-7C544554-34A3-4CC2-9FE2-A708DD38BE3CQ35563676-33043906-971B-4DFC-8F92-E2598DA130EDQ35664425-E274E135-9357-411E-9C6B-8A9A8C03F5BDQ35670773-847E4AB3-3187-4E71-BB1E-B92C1AE12370Q35908454-6F915B6A-66ED-44CA-893C-7091FA3EFF0BQ35954201-F88B7C11-EED2-489B-AB1F-D6F1FFB549E6Q36009095-19507718-7960-4ABC-96A0-79FA0FFE6C01Q36040781-9735AF52-87D8-41FC-9B1B-33794DA35245Q36287892-7486D2A7-2902-4075-A536-84143F1E2FC9
P2860
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@ast
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@en
type
label
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@ast
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@en
prefLabel
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@ast
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@en
P1433
P1476
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
@en
P2093
Giovanni Targher
Guido Arcaro
P304
P356
10.1016/J.ATHEROSCLEROSIS.2006.08.021
P577
2006-09-12T00:00:00Z